Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.23.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue        
Customer revenue $ 15,569 $ 5,112 $ 37,665 $ 19,760
Collaboration revenue 3,951 258 3,846 296
Total revenue 19,520 5,370 41,511 20,056
Operating expenses        
Research and development 9,595 13,589 37,347 39,602
General and administrative 6,839 3,949 14,526 12,409
Asset impairment 14,893 0 14,893 0
Total operating expenses 31,327 17,538 66,766 52,011
Loss from operations (11,807) (12,168) (25,255) (31,955)
Other income (expense)        
Interest income 549 241 1,396 370
Grant income 0 1,468 3,612 4,782
Other income (loss) 506 723 288 1,628
Net loss (10,752) (9,736) (19,959) (25,175)
Other comprehensive income loss:        
Foreign currency translation (204) (31) (159) (387)
Unrealized gain on available-for-sale securities 2 (70) 74 82
Comprehensive loss $ (10,954) $ (9,837) $ (20,044) $ (25,480)
Net loss per share        
Basic and diluted (in dollars per share) $ (0.11) $ (0.13) $ (0.23) $ (0.34)
Weighted average number of common shares outstanding        
Basic and diluted (in shares) 98,852 74,397 87,093 74,080